Genexine has ranked among the top searched stocks for 11 days in the past month.


As of 9:30 AM on the 28th, Genexine is trading at 119,500 KRW, up 0.17% from the previous day. This is a 21.79% decrease compared to December 7. Genexine is known as a company specializing in the development of biopharmaceuticals.

Over the past five days, individual investors have sold a net 78,716 shares, while foreigners and institutions have sold a net 45,510 shares and bought a net 133,088 shares, respectively.


On December 24, Genexine became a market issue with the news "Immune suppression candidate substance licensed to the U.S.... up 6%".



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing